SCHEMBL2180959

SCHEMBL2180959

CCCCCC(CCC)CN(C)C=O

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 1/20 0.38
ADH1C P00326 2/20 0.36
ADH1A P07327 2/20 0.36
ADH4 P08319 2/20 0.36
ADH1B P00325 1/20 0.36
ADH7 P40394 1/20 0.36
TRPA1 O75762 1/20 0.35
DDAH1 O94760 1/20 0.35
GAPDH P04406 1/20 0.35
MAPT P10636 1/20 0.35
TSHR P16473 3/20 0.32
PLA2G1B P04054 1/20 0.32
PLA2G2A P14555 1/20 0.32
SMN1; SMN2 Q16637 1/20 0.32
ALDH1A1 P00352 1/20 0.32
CYP3A4 P08684 1/20 0.32
FDPS P14324 4/20 0.31
OPRM1 P35372 1/20 0.31
GPR84 Q9NQS5 3/20 0.31
FFAR1 O14842 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5780119 0.90 TSHR (0.42) LMNAADH1CADH1AADH4ADH1B
SCHEMBL6553184 0.84 ALDH1A1 (0.48) LMNATSHRSMN1; SMN2ALDH1A1CYP3A4
SCHEMBL276852 0.82 LMNA (0.39) LMNAADH1CADH1AADH4ADH1B
SCHEMBL2177152 0.81 ADH1B (0.40) LMNAADH1CADH1AADH4ADH1B
SCHEMBL15020380 0.77 LMNA (0.44) LMNAPLA2G1BPLA2G2AALDH1A1FDPS
SCHEMBL16196082 0.76 LMNA (0.45) LMNAADH1CADH1AADH4ADH1B
SCHEMBL5191860 0.75 LMNA (0.48) LMNATSHRPLA2G1BPLA2G2AFDPS
SCHEMBL5192381 0.75 LMNA (0.48) LMNATSHRPLA2G1BPLA2G2AFDPS
SCHEMBL15056445 0.74 LMNA (0.46) LMNATSHRPLA2G1BPLA2G2AALDH1A1
SCHEMBL22592576 0.74 LMNA (0.41) LMNATSHRPLA2G1BPLA2G2AALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 51 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-106455574-B Foam formulations and emulsifiable concentrates FMC有限公司 2020-12-01 CN claimed
US-10631535-B2 Foam formulations and emulsifiable concentrates FMC CORPORATION (US) 2020-04-28 US claimed
EP-3160226-B1 FOAM FORMULATIONS FMC CORP (US) 2019-09-18 EP claimed
EP-3160226-A1 FOAM FORMULATIONS AND EMULSIFIABLE CONCENTRATES FMC CORPORATION (US) 2017-05-03 EP claimed
CN-106455574-A Foam formulations and emulsifiable concentrates FMC有限公司 2017-02-22 CN claimed
WO-2015200428-A1 FOAM FORMULATIONS AND EMULSIFIABLE CONCENTRATES FMC CORPORATION (US) 2015-12-30 WO claimed
US-20150366187-A1 FOAM FORMULATIONS AND EMULSIFIABLE CONCENTRATES FMC CORPORATION 2015-12-24 US claimed
US-20230389555-A1 IN SITU TREATMENT OF SEED IN FURROW FMC CORP (US) 2023-12-07 US disclosed
EP-4234724-A2 BACILLUS THURINGIENSIS RTI545 COMPOSITIONS AND METHODS OF USE FOR BENEFITTING PLANT GROWTH AND CONTROLLING PLANT PESTS FMC Agricultural Solutions A/S (DK) 2023-08-30 EP disclosed
EP-3522706-B1 BACILLUS THURINGIENSIS RTI545 COMPOSITIONS AND METHODS OF USE FOR BENEFITTING PLANT GROWTH AND CONTROLLING PLANT PESTS FMC AGRICULTURAL SOLUTIONS AS (DK) 2023-06-07 EP disclosed
US-11632959-B2 In situ treatment of seed in furrow FMC CORPORATION (US) 2023-04-25 US disclosed
US-RE49311-E1 Bacillus thuringiensis RTI545 compositions and methods of use for benefiting plant growth and controlling plant pests FMC CORPORATION (US) 2022-11-29 US disclosed
CN-110087460-B Bacillus thuringiensis RTI545 compositions and methods of use for benefiting plant growth and controlling plant pests FMC 公司 2022-06-28 CN disclosed
EP-2519498-B1 AMIDES, USE OF AMIDES AS SOLVENTS FOR ORGANIC COMPOUNDS, COMPOSITIONS AND EMULSIONS CONTAINING AMIDES, AND METHOD FOR TREATING A PLANT AKZO NOBEL CHEMICALS INT BV (NL) 2014-08-13 EP disclosed
CN-103945691-A Agricultural formulations with amides and acyl morpholines AKZO NOBEL CHEMICALS INT BV 2014-07-23 CN disclosed
WO-2013076200-A1 AGRICULTURAL FORMULATIONS WITH AMIDES AND ACYL MORPHOLINES AKZO NOBEL CHEMICALS INTERNATIONAL B.V. (NL) 2013-05-30 WO disclosed
US-20120283103-A1 Amides, use of Amides as Solvents for Organic Compounds, Compositions and Emulsions Containing Amides, and Method for Treating a Plant AKZO NOBEL CHEMICALS INTERNATIONAL B.V. (NL) 2012-11-08 US disclosed
EP-2519498-A1 AMIDES, USE OF AMIDES AS SOLVENTS FOR ORGANIC COMPOUNDS, COMPOSITIONS AND EMULSIONS CONTAINING AMIDES, AND METHOD FOR TREATING A PLANT Akzo Nobel Chemicals International B.V. (NL) 2012-11-07 EP disclosed
CN-102666477-A Amides, use of amides as solvents for organic compounds, compositions and emulsions containing amides, and method for treating a plant AKZO NOBEL CHEMICALS INT BV 2012-09-12 CN disclosed
WO-2011080208-A1 AMIDES, USE OF AMIDES AS SOLVENTS FOR ORGANIC COMPOUNDS, COMPOSITIONS AND EMULSIONS CONTAINING AMIDES, AND METHOD FOR TREATING A PLANT AKZO NOBEL CHEMICALS INTERNATIONAL B.V. (NL) 2011-07-07 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120283103-A1 Amides, use of Amides as Solvents for Organic Compounds, Compositions and Emulsions Containing Amides, and Method for Treating a Plant ACMSD, ABHD5, H1-0 LMNA 3501/4885ADH1C 168/4885ADH1A 173/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.